- Endogenous Incretin Hormone– GLP-1 is a naturally occurring peptide produced in the gut, studied for its role in regulating glucose metabolism and appetite.
- Diabetes Research– Extensively investigated for enhancing insulin secretion, reducing glucagon release, and improving glycemic control.
- Weight Management– Shown to reduce appetite and food intake in preclinical and clinical studies, supporting obesity research.
- Cardiovascular Protection– Research suggests GLP-1 may support heart health by reducing blood pressure, improving lipid levels, and protecting blood vessels.
- Neuroprotection– Early studies explore potential roles in cognition and protection against neurodegenerative diseases.
- Therapeutic Analogs– Native GLP-1 has a short half-life; synthetic analogs (e.g., Semaglutide, Liraglutide, Dulaglutide) are widely studied for extended activity.
